Improving risk classification of critical illness with biomarkers: A simulation study

Journal of Critical Care

Volumn 28, Issue 5, 2013, Pages 541-548

  Seymour, Christopher W ^a   Cooke, Colin R ^b   Wang, Zheyu ^c   Kerr, Kathleen F ^c   Yealy, Donald M ^a   Angus, Derek C ^a   Rea, Thomas D ^d   Kahn, Jeremy M ^a,e   Pepe, Margaret S ^c,f  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Biomarker; Reclassification; Sample size; Simulation

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CRITICAL ILLNESS; EMERGENCY HEALTH SERVICE; HIGH RISK PATIENT; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; PREDICTION; RISK ASSESSMENT; SIMULATION;

BIOMARKER; RECLASSIFICATION; SAMPLE SIZE; SIMULATION;

BIOLOGICAL MARKERS; CRITICAL ILLNESS; EMERGENCY SERVICE, HOSPITAL; HUMANS; RISK ASSESSMENT; TRIAGE;

EID: 84883558813     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2012.12.001     Document Type: Article

References (31)

1. Angus D.C., Shorr A.F., White A., et al. Critical care delivery in the United States: distribution of services and compliance with Leapfrog recommendations. Crit Care Med 2006, 34(4):1016-1024.
2. IOM Hospital based emergency care: at the breaking point. Committee on the Future of Emergency Care in the United States Health System 2007, National Academies Press, Washington, DC.
3. Barnato A.E., Kahn J.M., Rubenfeld G.D., et al. Prioritizing the organization and management of intensive care services in the United States: the PrOMIS Conference. Crit Care Med 2007, 35(4):1003-1011.
4. Kahn J.M., Linde-Zwirble W.T., Wunsch H., et al. Potential value of regionalized intensive care for mechanically ventilated medical patients. Am J Respir Crit Care Med 2008, 177(3):285-291.
5. Seymour C.W., Kahn J.M., Cooke C.R., et al. Prediction of critical illness during out-of-hospital emergency care. JAMA 2010, 304(7):747-754.
6. Wells P.S., Anderson D.R., Rodger M., et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Ann Intern Med 2001, 135(2):98-107.
7. Mills N.L., Churchhouse A.M., Lee K.K., et al. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA 2011, 305(12):1210-1216.
8. Jones AE, Shapiro NI, Trzeciak S, et al. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA 303(8):739-46.
9. Jansen T.C., van Bommel J., Mulder P.G., et al. The prognostic value of blood lactate levels relative to that of vital signs in the pre-hospital setting: a pilot study. Crit Care 2008, 12(6):R160.
10. Cook N.R., Ridker P.M. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Ann Intern Med 2009, 150(11):795-802.
11. Aufderheide T.P., Hendley G.E., Thakur R.K., et al. The diagnostic impact of prehospital 12-lead electrocardiography. Ann Emerg Med 1990, 19(11):1280-1287.
12. Mikkelsen M.E., Miltiades A.N., Gaieski D.F., et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med 2009, 37(5):1670-1677.
13. Nguyen H.B., Rivers E.P., Knoblich B.P., et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 2004, 32(8):1637-1642.
14. del Portal D.A., Shofer F., Mikkelsen M.E., et al. Emergency department lactate is associated with mortality in older adults admitted with and without infections. Acad Emerg Med 2010, 17(3):260-268.
15. Jones A.E., Shapiro N.I., Trzeciak S., et al. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA 2010, 303(8):739-746.
16. Seymour C.W., Band R.A., Cooke C.R., et al. Out-of-hospital characteristics and care of patients with severe sepsis: a cohort study. J Crit Care 2010, 25(4):553-562.
17. Pencina M.J., D'Agostino R.B., D'Agostino R.B., et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008, 27(2):157-172. [discussion 207-112].
18. Kerr K.F., McClelland R.L., Brown E.R., Lumley T. Evaluating the incremental value of new biomarkers with integrated discrimination improvement. Am J Epidemiol 2011, 174(3):364-374.
19. Zethelius B., Berglund L., Sundstrom J., et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008, 358(20):2107-2116.
20. Thompson I.M., Ankerst D.P., Chi C., et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst 2006, 98(8):529-534.
21. Calfee C.S., Ware L.B., Glidden D.V., et al. Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury. Crit Care Med 2011, 39(4):711-717.
22. Pepe M.S., Janes H., Longton G., et al. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 2004, 159(9):882-890.
23. Huang D.T., Weissfeld L.A., Kellum J.A., et al. Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med 2008, 52(1):e42-e58.
24. Kaptoge S., Di Angelantonio E., Lowe G., et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010, 375(9709):132-140.
25. Morrow D.A., Cannon C.P., Rifai N., et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA 2001, 286(19):2405-2412.
26. Yende S., D'Angelo G., Kellum J.A., et al. Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med 2008, 177(11):1242-1247.
27. Ioannidis J.P., Panagiotou O.A. Comparison of effect sizes associated with biomarkers reported in highly cited individual articles and in subsequent meta-analyses. JAMA 2011, 305(21):2200-2210.
28. Shapiro N.I., Trzeciak S., Hollander J.E., et al. A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. Crit Care Med 2009, 37(1):96-104.
29. Sutherland A., Thomas M., Brandon R.A., et al. Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis. Crit Care 2011, 15(3):R149.
30. Wong H.R., Cvijanovich N.Z., Allen G.L., et al. Validation of a gene expression-based subclassification strategy for pediatric septic shock. Crit Care Med 2011, 39(11):2511-2517.
31. Rosenthal G.E., Sirio C.A., Shepardson L.B., et al. Use of intensive care units for patients with low severity of illness. Arch Intern Med 1998, 158(10):1144-1151.